Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IBP-9414
IBP-9414
Microbiome Report for Week Ending 5/18/19
Sun, 05/26/19 - 02:28 pm
microbiome
4D Pharma
Azitra
Vedanta Biosciences
Infant Bacterial Therapeutics
IBP-9414
SkinBio Therapeutics
Thetanix
Chron's Disease
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
CP Wire
Mon, 05/20/19 - 11:04 pm
Infant Bacterial Therapeutics
necrotizing enterocolitis
FDA
clinical trials
IBP-9414
Infant Bacterial Therapeutics AB Announces Distribution Agreement For Israeli Market
CP Wire
Thu, 03/7/19 - 09:54 am
Infant Bacterial Therapeutics
IBP-9414
necrotizing enterocolitis
Infant Bacterial Therapeutics AB Announces Distribution Agreement For Israeli Market
Thu, 03/7/19 - 09:46 am
Infant Bacterial Therapeutics
IBP-9414
necrotizing enterocolitis
Infant Bacterial Therapeutics Delays Ph III Start Date After Meeting with FDA
CP Wire
Sat, 11/24/18 - 11:11 am
Infant Bacterial Therapeutics
IBP-9414
necrotizing enterocolitis
Infant Bacterial Therapeutics Delays Ph III Start Date After Meeting with FDA
Sat, 11/24/18 - 11:06 am
Infant Bacterial Therapeutics
IBP-9414
necrotizing enterocolitis
